BOARD OF TRUSTEES

OBJECTIVES

The Board of Trustees of PharmACT is available for scientific support and the establishment of local academies, also to transport our services to organisations and industry.

The board of trustees advises the supervisory board and the management board of PharmACT  on questions of public relations, fundraising, positioning and development cooperation.
It supports the networks of the company or its partners.

The development of new contacts to companies, institutions and medical networks that promote the concerns of the Board of Trustees through its mediation in society or through access to public or private funds.

Prof. Dr. med. Abderahman Machraoui
Cardiologist, Clinical Trials; Bochum, Germany / Maroc

Dr. med. Alexander Strelnikow
Clinical Trials; St. Petersburg, Russ. Federation

Dr. med. Miguel Angel Lopez-Aranda
Cardiologist, Clinical Trials; Benidorm, Spain